Boston Medical Center
1 Boston Medical Center Place, Boston, MA, 02118 · (617) 638-8000
$1.74B
Net patient revenue, FY 2025
$1.74B
Net patient revenue, FY 2025
Beds
459
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$1.74B
FY 2025
Net income
-$30.7M
Patient care margin -72.4%
Discharges
22,603
Occupancy 89.2%
Clinicians
1,744
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
2 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.74B | $2.99B | -72.4% | -$30.7M | 22,603 | $143.9M | 18.6% | 19.9% |
| 2024 | $1.53B | $2.66B | -73.2% | -$51.6M | 22,898 | $124.0M | 16.6% | 19.7% |
| 2023 | $1.41B | $2.42B | -71.9% | -$70.5M | 21,870 | $128.2M | 15.6% | 20.3% |
| 2022 | $1.19B | $2.13B | -78.4% | -$21.2M | 21,560 | $97.9M | 18.0% | 12.5% |
| 2021 | $1.17B | $1.91B | -64.3% | $15.4M | 22,667 | $95.6M | 22.6% | 18.0% |
| 2020 | $1.14B | $1.79B | -56.0% | $225.1M | 21,754 | $100.2M | 21.1% | 17.0% |
Quality of care
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
Death rates
| Death rate after heart bypass surgery | 2.5% | US median 2.3% |
| Death rate for COPD patients | 7% | US median 8.5% |
| Death rate for heart attack patients | 11.7% | US median 11.8% |
| Death rate for heart failure patients | 6.6% | US median 11% |
| Hospital-wide death rate within 30 days | 3.1% | US median 3.9% |
| Death rate for pneumonia patients | 11.9% | US median 15.2% |
| Death rate for stroke patients | 11.9% | US median 11.6% |
Readmissions
| Readmission rate after heart bypass surgery | 10.9% | US median 10.9% |
| Readmission rate for COPD | 21.9% | US median 19.8% |
| Readmission rate after a heart attack | 14.6% | US median 14.4% |
| Readmission rate for heart failure | 21.4% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.1% | US median 5.8% |
| Readmission rate for pneumonia | 18.5% | US median 17.2% |
Patient safety
| Complications after hip or knee replacement | 3.7% | US median 4.1% |
| Serious complications (patient safety composite) | 1.14 | US median 0.96 |
Infections
| C. diff intestinal infections (ratio to expected) | 0.57 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.14 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.60 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 0.43 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.44 | US median 0.60 · better |
| Catheter urinary tract infections (ratio to expected) | 0.56 | US median 0.40 · better |
Patient survey
| Doctors always communicated well | 79% | US median 79% |
| Nurses always communicated well | 79% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 53% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 71% | US median 72% |
| Room and bathroom always clean | 71% | US median 73% |
| Patients who would definitely recommend the hospital | 73% | US median 71% |
Timely and effective care
| Patients who left the emergency department before being seen | 7% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 227 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 15% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 62% | US median 65% |
| Healthcare workers given the flu vaccine | 95% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 56% | US median 74% |
Hospital profile
- Medicare certification number (CCN)
- 220031
- Organization NPI
- 1346218294
- Legal name
- Boston Medical Center Corporation
- County
- Suffolk County, MA
- Ownership
- Nonprofit (private)
- Teaching
- Limited teaching
- In Medicare since
- 1966
- Full-time employees
- 8,030
- Health system
- Boston Medical Center
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other Boston Medical Center hospitals
| Hospital | Place |
|---|---|
| Good Samaritan Medical Center | Brockton, MA |
Other hospitals in Boston
Similar short-term acute care hospitals in Massachusetts
Closest in number of beds
| Hospital | Place | Beds |
|---|---|---|
| South Shore Hospital | South Weymouth, MA | 394 |
| Lowell General Hospital | Lowell, MA | 390 |
| Tufts Medical Center | Boston, MA | 371 |
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | 343 |
| Northeast Hospital Corporation | Beverly, MA | 335 |
| Southcoast Hospitals Group | Fall River, MA | 656 |
Medicare hospital stays
Inpatient stays by diagnosis related group (DRG), 2024
| Diagnosis group | Stays | Average charge | Medicare pays per stay | All hospitals |
|---|---|---|---|---|
| DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | 160 | $71,542.03 | $30,289.56 | $15,524.21 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 152 | $38,088.92 | $19,671.03 | $10,022.34 |
| DRG 885 PSYCHOSES | 66 | $78,853.21 | $23,374.62 | $11,869.17 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 56 | $88,709.88 | $31,479.16 | $15,695.20 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 48 | $47,664.75 | $25,177.77 | $12,667.88 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 46 | $180,648.39 | $76,095.87 | $40,556.82 |
| DRG 286 CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATHETERIZATION WITH MCC | 40 | $83,862.85 | $32,616.45 | $17,632.75 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 39 | $55,788.36 | $25,090.33 | $13,076.55 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 39 | $30,881.26 | $20,364.72 | $10,642.23 |
| DRG 190 CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | 37 | $30,800.24 | $17,642.68 | $8,466.56 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 35 | $27,911.77 | $15,743.97 | $7,294.77 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 34 | $44,833.38 | $15,214.82 | $7,474.08 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 32 | $36,715.47 | $20,682.63 | $9,867.73 |
| DRG 057 DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC | 31 | $71,502.81 | $21,017.74 | $11,625.30 |
| DRG 683 RENAL FAILURE WITH CC | 31 | $22,363.84 | $14,426.87 | $6,629.69 |
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 928 | 696 | $2,328.73 | $2,090.36 |
| APC 5372 Level 2 Urology and Related Services | 384 | 235 | $573.27 | $502.15 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 201 | 190 | $1,365.46 | $1,219.56 |
| APC 5491 Level 1 Intraocular Procedures | 183 | 147 | $1,983.14 | $1,751.67 |
| APC 5164 Level 4 ENT Procedures | 151 | 73 | $1,402.46 | $2,217.17 |
| APC 5373 Level 3 Urology and Related Services | 125 | 115 | $1,712.40 | $1,516.28 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 107 | 105 | $2,385.52 | $2,141.49 |
| APC 5183 Level 3 Vascular Procedures | 80 | 75 | $2,693.35 | $2,405.01 |
| APC 5165 Level 5 ENT Procedures | 64 | 61 | $4,971.83 | $4,436.36 |
| APC 5113 Level 3 Musculoskeletal Procedures | 59 | 49 | $2,300.25 | $2,373.24 |
| APC 5213 Level 3 Electrophysiologic Procedures | 57 | 55 | $23,803.95 | $21,117.37 |
| APC 5191 Level 1 Endovascular Procedures | 57 | 56 | $2,512.74 | $2,207.96 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $1.1M |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $1.1M |
| Merck Sharp & Dohme LLC | 14 | $842K |
| Janssen Research & Development, LLC | 44 | $364K |
| Pfizer Inc. | 26 | $352K |
| Genentech, Inc. | 25 | $335K |
| Vertex Pharmaceuticals Incorporated | 2 | $297K |
| Zevra Therapeutics Inc | 3 | $214K |
| Theratechnologies Inc. | 4 | $192K |
| Madrigal Pharmaceuticals | 30 | $189K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.